Thromboembolic risk rises without anticoagulants after cardioversion

07/19/2013 | Healio

A 5,116-participant study found that patients who are at risk of thromboembolism are more likely to suffer thromboembolic events if they are not treated with anticoagulants following cardioversion of acute atrial fibrillation. The results affirm the European Society of Cardiology's 2010 recommendation that acute AF patients receive anticoagulants, specifically heparin peri-cardioversion followed by long-term use of a vitamin K antagonist during and after restoration of normal heart rhythm.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC